Swiss Re Ltd. (OTCMKTS:SSREY – Get Free Report) saw a large decline in short interest during the month of February. As of February 13th, there was short interest totaling 25,986 shares, a decline of 31.7% from the January 29th total of 38,074 shares. Based on an average trading volume of 123,215 shares, the short-interest ratio is presently 0.2 days. Approximately 0.0% of the shares of the stock are short sold. Approximately 0.0% of the shares of the stock are short sold. Based on an average trading volume of 123,215 shares, the short-interest ratio is presently 0.2 days.
Swiss Re Price Performance
OTCMKTS SSREY opened at $44.03 on Friday. Swiss Re has a 1-year low of $37.56 and a 1-year high of $48.62. The stock has a 50-day moving average of $40.95 and a 200-day moving average of $43.47.
Analyst Ratings Changes
A number of research firms have weighed in on SSREY. The Goldman Sachs Group downgraded Swiss Re from a “hold” rating to a “sell” rating in a research report on Wednesday, January 21st. Berenberg Bank lowered Swiss Re from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, December 9th. UBS Group downgraded Swiss Re from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, December 17th. Oddo Bhf lowered Swiss Re to a “neutral” rating in a research note on Tuesday, December 9th. Finally, Royal Bank Of Canada reissued an “underperform” rating on shares of Swiss Re in a research note on Monday, December 8th. One equities research analyst has rated the stock with a Strong Buy rating, four have issued a Hold rating and four have issued a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Reduce”.
About Swiss Re
Swiss Re (OTCMKTS: SSREY) is a global reinsurance company headquartered in Zurich, Switzerland. Founded in 1863, the firm provides risk transfer and insurance solutions to insurers, reinsurers, and large corporations worldwide. Its core activities encompass reinsurance for property & casualty and life & health lines, as well as tailored corporate insurance products designed to protect complex commercial and industrial risks.
Swiss Re’s product offering spans treaty and facultative reinsurance, structured reinsurance solutions, and capital markets–linked risk transfer such as insurance‑linked securities.
Further Reading
- Five stocks we like better than Swiss Re
- The gold chart Wall Street is terrified of…
- This makes me furious
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for Swiss Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Swiss Re and related companies with MarketBeat.com's FREE daily email newsletter.
